Amyloid Beta

1 article

An advanced AI system analyzing genetic data and brain scans to identify targets for Alzheimer's disease research.

AI accelerates Alzheimer's research into genetic targets

By age 65, almost all individuals with two copies of the APOE4 gene variant had abnormal levels of the Alzheimer's biomarker amyloid beta in their cerebrospinal fluid, according to NIH .

Arjun Mehta·April 22, 2026